Compare · HQL vs TROW
HQL vs TROW
Side-by-side comparison of abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) and T. Rowe Price Group Inc. (TROW): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HQL and TROW operate in Investment Managers (Finance), so they compete in similar markets.
- TROW is the larger of the two at $23.13B, about 49.8x HQL ($464.5M).
- TROW has hit the wire 5 times in the past 4 weeks while HQL has been quiet.
- TROW has more recent analyst coverage (25 ratings vs 0 for HQL).
abrdn Life Sciences Investors Shares of Beneficial Interest
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
T. Rowe Price Group Inc.
T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It employs fundamental and quantitative analysis with a bottom-up approach. The firm utilizes in-house and external research to make its investments. It employs socially responsible investing with a focus on environmental, social, and governance issues. It makes investment in late-stage venture capital transactions and usually invests between $3 million and $5 million. The firm was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland, with additional offices in Colorado Springs, Colorado; Owings Mills, Maryland; San Francisco, California; New York, New York; Philadelphia, Pennsylvania; Tampa, Florida; Toronto, Ontario; Hellerup, Denmark; Amsterdam, The Netherlands; Luxembourg, Grand Duchy of Luxembourg; Zurich, Switzerland; Dubai, United Arab Emirates; London, United Kingdom; Sydney, New South Wales; Hong Kong; Tokyo, Japan; Singapore; Frankfurt, Germany, Madrid, Spain, Milan, Italy, Stockholm, Sweden, Melbourne, Australia, and Amsterdam, Netherlands.
Latest HQL
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Director Mahai Chris Lavictoire bought $10,498 worth of shares (527 units at $19.92) (SEC Form 4)
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
- SEC Form 3 filed by new insider Mahai Chris Lavictoire
- SEC Form N-CSRS filed by abrdn Life Sciences Investors Shares of Beneficial Interest
- ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
- Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
- Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Latest TROW
- T. ROWE PRICE GROUP, INC., DECLARES QUARTERLY DIVIDEND
- SEC Form 10-Q filed by T. Rowe Price Group Inc.
- SEC Form 8-K filed by T. Rowe Price Group Inc.
- T. ROWE PRICE GROUP REPORTS THIRD QUARTER 2026 RESULTS
- SEC Form 4 filed by T. Rowe Price Group Inc.
- T. ROWE PRICE MOVES TO DEEPEN AND EXPAND ENGAGEMENT WITH WEALTH ADVISORS
- T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR SEPTEMBER 2026
- UBS resumed coverage on T. Rowe Price with a new price target
- T. ROWE PRICE LAUNCHES DYNAMIC EMERGING MARKETS BOND EXCHANGE TRADED FUND
- Director Wijnberg Sandra S was granted 164 shares, increasing direct ownership by 0.51% to 32,187 units (SEC Form 4)